Chembio Diagnostics, Inc (PINK:CEMI) is supposed to file its 10-Q for the first quarter of the year today and yesterday the stock entered the market with a gap up in anticipation of the event. Two days ago, the company also announced the regulatory approval to market another product in Brazil, thus no wonder that CEMI is again quickly up after the drawback. Yesterday, CEMI gained 3.70% in value and closed at $0.56 for a share. The intense activity before the filing of the latest financial results caused a volume of over 358,000 traded shares, more than twice the daily average...